↓ Skip to main content

Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy

Overview of attention for article published in Medical Oncology, September 2009
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
67 Mendeley
Title
Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy
Published in
Medical Oncology, September 2009
DOI 10.1007/s12032-009-9307-8
Pubmed ID
Authors

Guang-hui Li, Dong-lin Wang, Yi-de Hu, Ping Pu, De-zhi Li, Wei-dong Wang, Bo Zhu, Ping Hao, Jun Wang, Xian-qiong Xu, Jiu-qing Wan, Yi-bing Zhou, Zheng-tang Chen

Abstract

Radiation-induced acute intestinal symptoms (RIAISs) are the most relevant complication of abdominal or pelvic radiation. Considering the negative impact of RIAIS on patients' daily activities, the preventive effects of berberine on RIAIS in patients were investigated. Thirty-six patients with seminoma or lymphomas were randomized to receive berberine oral (n = 18) or not (n = 18). Forty-two patients with cervical cancer were randomized to a trial group (n = 21) and control group (n = 21). Radiotherapy used a parallel opposed anterior and posterior. 300-mg berberine was administered orally three times daily in trial groups. Eight patients with RIAIS were treated with 300-mg berberine three times daily from the third to the fifth week. Toxicities, such as fatigue, anorexia/nausea, etc., were graded weekly according to CTC version 2.0. Patients with abdominal/pelvic radiation in the control group showed grade 1 fatigue, anorexia/nausea, colitis, vomiting, proctitis, weight loss, diarrhea and grade 2 anorexia/nausea, fatigue. Only grade 1 colitis, anorexia/nausea, and fatigue were seen in patients of abdominal radiation treated with berberine. Grade 1 fatigue, colitis, anorexia/nausea, and proctitis occurred in patients of pelvic radiotherapy treated with berberine. Pretreatment with berberine significantly decreased the incidence and severity of RIAIS in patients with abdominal/pelvic radiotherapy when compared with the patients of the control group (P < 0.05). RIAIS were reduced in patients with abdominal radiotherapy/pelvic radiation after receiving berberine treatment. Berberine significantly reduced the incidence and severity of RIAIS and postponed the occurrence of RIAIS in patients with abdominal or whole pelvic radiation.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 3%
France 1 1%
Unknown 64 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 19%
Other 9 13%
Student > Master 8 12%
Student > Doctoral Student 7 10%
Student > Bachelor 7 10%
Other 12 18%
Unknown 11 16%
Readers by discipline Count As %
Medicine and Dentistry 31 46%
Pharmacology, Toxicology and Pharmaceutical Science 4 6%
Agricultural and Biological Sciences 4 6%
Biochemistry, Genetics and Molecular Biology 3 4%
Nursing and Health Professions 2 3%
Other 8 12%
Unknown 15 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 October 2018.
All research outputs
#18,397,250
of 22,787,797 outputs
Outputs from Medical Oncology
#793
of 1,289 outputs
Outputs of similar age
#74,115
of 81,110 outputs
Outputs of similar age from Medical Oncology
#11
of 12 outputs
Altmetric has tracked 22,787,797 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,289 research outputs from this source. They receive a mean Attention Score of 3.0. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 81,110 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 4th percentile – i.e., 4% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.